Pfizer : PFE

All Pfizer Articles

1494 Articles

Trey Thoelcke | Mar 27, 2018 at 6:15 AM EDT

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the February 28 and March 15…

Paul Ausick | Mar 23, 2018 at 4:01 PM EDT

DowDuPont, 3M Sink the Dow Friday

DowDuPont, Goldman Sachs, 3M Company, and Pfizer pushed the Dow lower again Friday.

Chris Lange | Mar 23, 2018 at 10:25 AM EDT

Pfizer’s Chantix Study Goes Up in Smoke

Pfizer shares slipped slightly on Friday after the pharma giant announced results from its Chantix/Champix smoking cessation study in adolescents.

Chris Lange | Mar 12, 2018 at 8:35 AM EDT

Major Pharma Sees Big Drop in Short Interest

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Mar 12, 2018 at 7:00 AM EDT

GE and Intel Remain Short Sellers’ Favorite Dow Stocks

As of the most recently reported period, short sellers still favored just two Dow stocks, General Electric and Intel, above…

Paul Ausick | Mar 8, 2018 at 4:07 PM EST

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

The Dow wobbled around Thursday and looks set to close very near the break-even line as J&J, Pfizer, Caterpillar, and…

Chris Lange | Feb 28, 2018 at 9:10 AM EST

Short Sellers Hike Bets in Major Pharma

The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Feb 22, 2018 at 2:52 PM EST

Should Gilead Just Have Tried to Acquire Sangamo Rather Than a Collaboration Pact?

If the collaboration between Sangamo and Kite Pharma works out, some investors might just ask why Gilead did not just acquire Sangamo.

Paul Ausick | Feb 16, 2018 at 4:01 PM EST

Pfizer, UnitedHealth Boost DJIA on Friday

Pfizer, UnitedHealth, Disney, and Johnson & Johnson lifted the DJIA on Friday.

Chris Lange | Feb 12, 2018 at 9:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Feb 8, 2018 at 8:15 AM EST

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Four large-cap pharmaceutical leaders are rated Overweight at JPMorgan, and all make sense for growth accounts looking for some safety…

Jon C. Ogg | Jan 31, 2018 at 1:55 PM EST

10 Stocks Seeing Multiple Analyst Upgrades After Earnings and Key News

These are the 10 stocks tracked by 24/7 Wall St. that received multiple analyst rating upgrades or price target hikes…

Jon C. Ogg | Jan 31, 2018 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AK Steel, Apple, Biogen, Electronic Arts, FitBit, Foot…

Paul Ausick | Jan 30, 2018 at 4:01 PM EST

UnitedHealth, Pfizer Tank the DJIA Tuesday

UnitedHealth, Pfizer, McDonald's, and General Electric put in a dismal day and led the DJIA to steep loss Tuesday.

Paul Ausick | Jan 30, 2018 at 7:55 AM EST

Pfizer Earnings, Guidance May Not Be Enough for Investors

Pharmaceuticals giant Pfizer beat quarterly and full-year expectations this morning, but the beats were small and the forecast for next…

1 … 36 37 38 39 40 … 100

Pfizer : PFE

All Pfizer Articles

The 6 Most Shorted NYSE Stocks

DowDuPont, 3M Sink the Dow Friday

Pfizer’s Chantix Study Goes Up in Smoke

Major Pharma Sees Big Drop in Short Interest

GE and Intel Remain Short Sellers’ Favorite Dow Stocks

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

Short Sellers Hike Bets in Major Pharma

Should Gilead Just Have Tried to Acquire Sangamo Rather Than a Collaboration Pact?

Pfizer, UnitedHealth Boost DJIA on Friday

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

10 Stocks Seeing Multiple Analyst Upgrades After Earnings and Key News

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

UnitedHealth, Pfizer Tank the DJIA Tuesday

Pfizer Earnings, Guidance May Not Be Enough for Investors

Ripple and SBI Launch RLUSD in Japan After JFSA Approval

Here’s How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the “Strongest Move” for Social Security Benefits

Here's How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the "Strongest Move" for Social Security Benefits

Ripple and SBI Launch RLUSD in Japan After JFSA Approval

Here’s How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

Pfizer : PFE

All Pfizer Articles

The 6 Most Shorted NYSE Stocks

DowDuPont, 3M Sink the Dow Friday

Pfizer’s Chantix Study Goes Up in Smoke

Major Pharma Sees Big Drop in Short Interest

GE and Intel Remain Short Sellers’ Favorite Dow Stocks

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

Short Sellers Hike Bets in Major Pharma

Should Gilead Just Have Tried to Acquire Sangamo Rather Than a Collaboration Pact?

Pfizer, UnitedHealth Boost DJIA on Friday

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

10 Stocks Seeing Multiple Analyst Upgrades After Earnings and Key News

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

UnitedHealth, Pfizer Tank the DJIA Tuesday

Pfizer Earnings, Guidance May Not Be Enough for Investors

Ripple and SBI Launch RLUSD in Japan After JFSA Approval

Here’s How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the “Strongest Move” for Social Security Benefits

Featured Reads

Here's How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the "Strongest Move" for Social Security Benefits